Novation Contract Awarded to Nova Biomedical

Posted December 30th, 2011.

Nova Biomedical is pleased to announce an extension of its contract to provide multi-analyte point-of-care testing instrumentation to Novation through July 31, 2009.

Under the terms of the agreement, Nova Biomedical will provide our advanced series of StatProfileĀ® Critical Care Xpress (CCX) analyzers, reagents, and consumables, and our service contracts to Novation members, associates, and affiliates.

The agreement will provide Novation member organizations with the following price incentives:

Up to 33% off Nova’s instrument list price based on the number of instruments purchased
Up to 18% off Nova’s 2003 list price for reagents based on the number of instruments purchased
Additional volume discounts based on three tier levels for analyzers and consumables

In addition, Nova will offer Novation member organizations the following value-added programs:

  • Additions, deletions, and substitutions to the Base Test Menu based on the member’s specific needs
  • CO-Ox upgrade program


Nova Biomedical is the world leader in the development of whole blood analyzers to support the care of critically ill patients. Based upon pioneering biosensor technology, Nova instrument are designed for rapid measurement of blood gases, co-oximetry, metabolites, electrolytes, and hematology. Nova is the only point-of-care company that offers ionized magnesium, BUN, and creatinine on a single analyzer. Nova analyzers are used by small, medium, and large hospitals, as well as integrated health networks, to improve patient outcomes and reduce the cost of care.